Latest news
{{'2026-06-26T13:01:00Z' | dateFormatFilter}}
Novo Nordisk to showcase new data across its haemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig
{{'2026-06-11T15:30:50Z' | dateFormatFilter}}
Novo Nordisk A/S: IT Security incident at Novo Nordisk
{{'2026-06-07T21:31:24Z' | dateFormatFilter}}
Novo Nordisk’s CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
Investors
Share price
{{priceData.date}} {{priceData.time}}
{{priceData.currentPrice}}
{{priceData.currency}}
Go to stock watch
{{priceData.change}} {{priceData.currency}}
